Pine Bridge Investments, L.P. Xencor Inc Transaction History

Pine Bridge Investments, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$24.77 - $29.9 $16,546 - $19,973	668 New	668 $16,000
Q1 2020 May 14, 2020	SELL	$20.69 - $37.79 $523,457 - $956,087	-25,300 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$32.75 - $41.43 $414,156 - $523,923	-12,646 Reduced 33.33%	25,300 $870,000
Q3 2019 Nov 13, 2019	BUY	$33.73 - $46.27 $1.28 Million - $1.76 Million	37,946 New	37,946 $1.28 Million

214

71.8M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.09B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

Stay updated on Pine Bridge Investments, L.P. with notifications on news.